SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-221758
Filing Date
2014-06-02
Accepted
2014-06-02 13:37:54
Documents
1
Group Members
ATLAS ENHANCED FUND, L.P.ATLAS ENHANCED FUND, LTD.ATLAS ENHANCED MASTER FUND, LTD.ATLAS FUNDAMENTAL TRADING FUND, L.P.ATLAS FUNDAMENTAL TRADING FUND, LTD.ATLAS FUNDAMENTAL TRADING MASTER FUND, LTD.ATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL JAPAN UNIT TRUS

Document Format Files

Seq Description Document Type Size
1 SC 13G d734579dsc13g.htm SC 13G 356468
  Complete submission text file 0001193125-14-221758.txt   358640
Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86723 | Film No.: 14883357
SIC: 2834 Pharmaceutical Preparations